Dmytro Labudzynskyi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dmytro Labudzynskyi has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Olha Lisakovska
Department of Biochemistry of Vitamins and Coenzymes, Palladin Institute of Biochemistry, Kyiv, Ukraine
9 shared publications - Mykola M. Veliky
Palladin Institute of Biochemistry, The National Academy of Sciences of Ukraine, 02000 Kyiv, Ukraine
7 shared publications - Anna Mazanova
Department of Biochemistry of Vitamins and Coenzymes, Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, Kyiv, Ukraine
3 shared publications - Ihor Shymanskyy
Інститут біохімії ім. О.В. Палладіна НАН України
3 shared publications - Larysa V. Natrus
Bogomolets National Medical University, Kyiv, Ukraine
3 shared publications - Yuliia Klys
Department of Modern Technologies of Demical Diagnostics and Treatment, Bogomolets National Medical University, Kyiv, Ukraine
3 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (6)
Beyond calcium homeostasis: Vitamin D signaling in salivary gland biology and disease: Current evidence and emerging perspectives
- 3 November 2026
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (6)
Open AccessBeyond calcium homeostasis: Vitamin D signaling in salivary gland biology and disease: Current evidence and emerging perspectives
- Open Access
- 2 October 2026
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 22 (6) , 643-652
Effects of calcitonin and infrared laser therapy on serum markers of bone remodeling and inflammation following experimental bone defect in rats
Background. Optimization of reparative osteogenesis following traumatic bone injury remains an important challenge in regenerative medicine and experimental orthopedics, particularly in the context of osteoporosis and impaired bone healing. Serum markers of bone formation, bone resorption, and inflammation are widely used to evaluate the course of bone repair and the efficacy of therapeutic interventions. Therefore, the search for novel approaches capable of modulating reparative processes in bone tissue is of considerable scientific and clinical interest. Among such approaches, calcitonin administration and infrared laser irradiation have shown potential osteoprotective and immunomodulatory properties. The purpose of the study was to evaluate changes in serum markers of bone remodeling and inflammation following experimental bone injury in rats and to assess the effects of calcitonin and infrared laser irradiation on these parameters. Materials and methods. Reparative osteogenesis was investigated in an in vivo experiment involving 30 Wistar rats with standardized traumatic defects created in the mid-diaphyseal region of the tibia under general anesthesia. The animals were randomly assigned to five groups (n = 6 per group): group 1 — intact animals; group 2 — untreated rats with traumatic bone injury (control); group 3 — animals subjected to local infrared laser irradiation immediately after injury; group 4 — rats treated with calcitonin; and group 5 — animals receiving combined treatment with calcitonin and infrared laser irradiation. Serum concentrations of calcium and inorganic phosphate, alkaline phosphatase activity, and deoxypyridinoline (DPD) levels were determined as markers of bone tissue remodeling. Serum levels of interleukin-1β (IL-1β) and IL-10 were assessed as indicators of the systemic inflammatory response associated with experimental bone injury. Measurements were performed on postoperative days 7 and 28. Results. Therapeutic interventions promoted the restoration of serum inorganic phosphate concentrations toward control values, with the most pronounced effect observed following combined treatment with calcitonin and laser irradiation. Similar changes were detected for serum calcium concentrations, which approached the levels observed in intact animals, particularly in the combination therapy group. Infrared laser irradiation alone and in combination with calcitonin significantly increased alkaline phosphatase activity on postoperative day 7 and decreased its activity by day 28 compared to untreated animals, indicating enhanced osteoblastic activity and accelerated bone matrix formation during the early stages of reparative osteogenesis. Furthermore, calcitonin administration and laser irradiation significantly reduced serum DPD concentrations by postoperative day 28, whereas their combined application normalized DPD levels to those observed in intact animals, suggesting attenuation of bone resorption processes. A marked increase in IL-10 concentration was detected on postoperative day 7 in the treatment groups, reaching values 2.4-fold higher than those in untreated animals, which may reflect activation of anti-inflammatory mechanisms involved in tissue repair. By postoperative day 28, IL-10 concentrations had declined and approached control values, indicating resolution of the inflammatory response. Overall, the combined use of calcitonin and infrared laser irradiation demonstrated the most favorable effects on both bone remodeling and inflammatory markers. Conclusions. Calcitonin administration, infrared laser irradiation, and particularly their combined application exert beneficial effects on reparative osteogenesis and modulate the systemic inflammatory response following experimental bone injury in rats. Combined therapy was associated with the most pronounced normalization of mineral metabolism parameters, suppression of osteoresorption markers, and restoration of cytokine balance, suggesting its potential as a promising strategy for enhancing bone repair.
- 2 October 2026
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 22 (6) , 643-652
Open AccessEffects of calcitonin and infrared laser therapy on serum markers of bone remodeling and inflammation following experimental bone defect in rats
Background. Optimization of reparative osteogenesis following traumatic bone injury remains an important challenge in regenerative medicine and experimental orthopedics, particularly in the context of osteoporosis and impaired bone healing. Serum markers of bone formation, bone resorption, and inflammation are widely used to evaluate the course of bone repair and the efficacy of therapeutic interventions. Therefore, the search for novel approaches capable of modulating reparative processes in bone tissue is of considerable scientific and clinical interest. Among such approaches, calcitonin administration and infrared laser irradiation have shown potential osteoprotective and immunomodulatory properties. The purpose of the study was to evaluate changes in serum markers of bone remodeling and inflammation following experimental bone injury in rats and to assess the effects of calcitonin and infrared laser irradiation on these parameters. Materials and methods. Reparative osteogenesis was investigated in an in vivo experiment involving 30 Wistar rats with standardized traumatic defects created in the mid-diaphyseal region of the tibia under general anesthesia. The animals were randomly assigned to five groups (n = 6 per group): group 1 — intact animals; group 2 — untreated rats with traumatic bone injury (control); group 3 — animals subjected to local infrared laser irradiation immediately after injury; group 4 — rats treated with calcitonin; and group 5 — animals receiving combined treatment with calcitonin and infrared laser irradiation. Serum concentrations of calcium and inorganic phosphate, alkaline phosphatase activity, and deoxypyridinoline (DPD) levels were determined as markers of bone tissue remodeling. Serum levels of interleukin-1β (IL-1β) and IL-10 were assessed as indicators of the systemic inflammatory response associated with experimental bone injury. Measurements were performed on postoperative days 7 and 28. Results. Therapeutic interventions promoted the restoration of serum inorganic phosphate concentrations toward control values, with the most pronounced effect observed following combined treatment with calcitonin and laser irradiation. Similar changes were detected for serum calcium concentrations, which approached the levels observed in intact animals, particularly in the combination therapy group. Infrared laser irradiation alone and in combination with calcitonin significantly increased alkaline phosphatase activity on postoperative day 7 and decreased its activity by day 28 compared to untreated animals, indicating enhanced osteoblastic activity and accelerated bone matrix formation during the early stages of reparative osteogenesis. Furthermore, calcitonin administration and laser irradiation significantly reduced serum DPD concentrations by postoperative day 28, whereas their combined application normalized DPD levels to those observed in intact animals, suggesting attenuation of bone resorption processes. A marked increase in IL-10 concentration was detected on postoperative day 7 in the treatment groups, reaching values 2.4-fold higher than those in untreated animals, which may reflect activation of anti-inflammatory mechanisms involved in tissue repair. By postoperative day 28, IL-10 concentrations had declined and approached control values, indicating resolution of the inflammatory response. Overall, the combined use of calcitonin and infrared laser irradiation demonstrated the most favorable effects on both bone remodeling and inflammatory markers. Conclusions. Calcitonin administration, infrared laser irradiation, and particularly their combined application exert beneficial effects on reparative osteogenesis and modulate the systemic inflammatory response following experimental bone injury in rats. Combined therapy was associated with the most pronounced normalization of mineral metabolism parameters, suppression of osteoresorption markers, and restoration of cytokine balance, suggesting its potential as a promising strategy for enhancing bone repair.
- Open Access
- 1 August 2022
- Published by Zaporizhzhia State Medical and Pharmaceutical University in Zaporozhye Medical Journal
- Vol. 24 (4) , 431-439
Characteristics of the effect of exosomes isolated from donor plasma and placenta-derived mesenchymal stromal cell-conditioned medium on the paracrine secretion of human peripheral blood mononuclear cells
Позаклітинні дрібнорозмірні везикули – екзосоми – привертають увагу дослідників як перспективний інструмент регулювання міжклітинної комунікації. Терапевтичні ефекти, досягнуті за допомогою використання мезенхімальних стовбурових клітин (MSC), традиційно в медицині визначають як перевірену часом, багатовекторну стратегію лікування різних патологій. Так, окрім застосування безпосередньо MSC, актуальним є дослідження продуктів їх секреції. Мета роботи – вивчити особливості впливу екзосом, виділених із плазми крові здорових донорів і з кондиційного середовища культивування MSC плаценти, на паракринну секрецію мононуклеарних клітин крові пацієнтів із хронічною серцевою недостатністю (ХСН) in vitro. Матеріали та методи. Дослідження особливостей паракринної секреції мононуклеарних клітин крові пацієнтів із ХСН за вмістом протеїнів VEGF-А, МСР-1, ICAM-1 у середовищі їх культивації здійснили у двох напрямках експерименту: під дією екзосом, виділених із плазми крові здорових донорів, та екзосом, що виділені з середовища культивування MSC плаценти. Результати. Інкубація мононуклеарних клітин периферичної крові (peripheral blood mononuclear cell, РВМС) із плазматичними екзосомами сприяла підвищенню секреції VEGF-А у групі здорових донорів у 2,73 раза (р ≤ 0,05), у пацієнтів із ХСН – удвічі (р ≤ 0,05), а також мала різноспрямований ефект на вміст протеїну ICAM-1: в групі донорів він підвищувався в 1,8 раза (р ≤ 0,05), а в групі пацієнтів із ХСН зменшувався в 1,4 раза (р ≤ 0,05); секреція МСР-1 у групі донорів недостовірно знижувалася на 10 % та вірогідно не змінювалася у пацієнтів. Інкубація РВМС з екзосомами, що виділені з кондиційного середовища MSC, не викликала достовірних змін паракринної секреції РВМС: у групі здорових добровольців спостерігали зменшення секреції VEGF-А на 25 %, ICAM-1 – на 17 %, MCP-1 – на 22 %; у групі пацієнтів із ХСН секреція цих протеїнів зменшувалася на 19,7 %, 22,0 % та 25,0 % відповідно. Ефекти, що спостерігали при інкубації мононуклеарних клітин крові з екзосомами, виділеними з плазми крові здорових донорів і з кондиційного середовища культивування MSC плаценти, дають цінну інформацію щодо дизайну майбутніх досліджень у цьому напрямі клітинної біології. Висновки. Дослідження на моделі in vitro показали особливості впливу екзосом, що виділені з плазми донорів і кондиційного середовища, на функціональні властивості мононуклеарних клітин периферичної крові людини.
- 1 August 2022
- Published by Zaporizhzhia State Medical and Pharmaceutical University in Zaporozhye Medical Journal
- Vol. 24 (4) , 431-439
Open AccessCharacteristics of the effect of exosomes isolated from donor plasma and placenta-derived mesenchymal stromal cell-conditioned medium on the paracrine secretion of human peripheral blood mononuclear cells
Позаклітинні дрібнорозмірні везикули – екзосоми – привертають увагу дослідників як перспективний інструмент регулювання міжклітинної комунікації. Терапевтичні ефекти, досягнуті за допомогою використання мезенхімальних стовбурових клітин (MSC), традиційно в медицині визначають як перевірену часом, багатовекторну стратегію лікування різних патологій. Так, окрім застосування безпосередньо MSC, актуальним є дослідження продуктів їх секреції. Мета роботи – вивчити особливості впливу екзосом, виділених із плазми крові здорових донорів і з кондиційного середовища культивування MSC плаценти, на паракринну секрецію мононуклеарних клітин крові пацієнтів із хронічною серцевою недостатністю (ХСН) in vitro. Матеріали та методи. Дослідження особливостей паракринної секреції мононуклеарних клітин крові пацієнтів із ХСН за вмістом протеїнів VEGF-А, МСР-1, ICAM-1 у середовищі їх культивації здійснили у двох напрямках експерименту: під дією екзосом, виділених із плазми крові здорових донорів, та екзосом, що виділені з середовища культивування MSC плаценти. Результати. Інкубація мононуклеарних клітин периферичної крові (peripheral blood mononuclear cell, РВМС) із плазматичними екзосомами сприяла підвищенню секреції VEGF-А у групі здорових донорів у 2,73 раза (р ≤ 0,05), у пацієнтів із ХСН – удвічі (р ≤ 0,05), а також мала різноспрямований ефект на вміст протеїну ICAM-1: в групі донорів він підвищувався в 1,8 раза (р ≤ 0,05), а в групі пацієнтів із ХСН зменшувався в 1,4 раза (р ≤ 0,05); секреція МСР-1 у групі донорів недостовірно знижувалася на 10 % та вірогідно не змінювалася у пацієнтів. Інкубація РВМС з екзосомами, що виділені з кондиційного середовища MSC, не викликала достовірних змін паракринної секреції РВМС: у групі здорових добровольців спостерігали зменшення секреції VEGF-А на 25 %, ICAM-1 – на 17 %, MCP-1 – на 22 %; у групі пацієнтів із ХСН секреція цих протеїнів зменшувалася на 19,7 %, 22,0 % та 25,0 % відповідно. Ефекти, що спостерігали при інкубації мононуклеарних клітин крові з екзосомами, виділеними з плазми крові здорових донорів і з кондиційного середовища культивування MSC плаценти, дають цінну інформацію щодо дизайну майбутніх досліджень у цьому напрямі клітинної біології. Висновки. Дослідження на моделі in vitro показали особливості впливу екзосом, що виділені з плазми донорів і кондиційного середовища, на функціональні властивості мононуклеарних клітин периферичної крові людини.
- Open Access
- 22 January 2022
- Published by Wiley in Neural Plasticity
- Vol. 2022, 1-26
Effect of Propionic Acid on Diabetes-Induced Impairment of Unfolded Protein Response Signaling and Astrocyte/Microglia Crosstalk in Rat Ventromedial Nucleus of the Hypothalamus
Background. The aim was to investigate the influence of propionic acid (PA) on the endoplasmic reticulum (ER), unfolded protein response (UPR) state, and astrocyte/microglia markers in rat ventromedial hypothalamus (VMH) after type 2 diabetes mellitus (T2DM). Methods. Male Wistar rats were divided: (1) control, (2) T2DM, and groups that received the following (14 days, orally): (3) metformin (60mg/kg), (4) PA (60mg/kg), and (5) PA+metformin. Western blotting, RT-PCR, transmission electron microscopy, and immunohistochemical staining were performed. Results. We found T2DM-associated enlargement of ER cisterns, while drug administration slightly improved VMH ultrastructural signs of damage. GRP78 level was 2.1-fold lower in T2DM vs. control. Metformin restored GRP78 to control, while PA increased it by 2.56-fold and metformin+PAby 3.28-fold vs. T2DM. PERK was elevated by 3.61-fold in T2DM, after metforminby 4.98-fold, PA5.64-fold, and metformin+PA3.01-fold vs. control. A 2.45-fold increase in ATF6 was observed in T2DM. Metformin decreased ATF6 content vs. T2DM. Interestingly, PA exerted a more pronounced lowering effect on ATF6, while combined treatment restored ATF6 to control. IRE1 increased in T2DM (2.4-fold), metformin (1.99-fold), and PA (1.45-fold) groups vs. control, while metformin+PA fully normalized its content. The Iba1 level was upregulated in T2DM (5.44-fold) and metformin groups (6.88-fold). Despite PA treatment leading to a further 8.9-fold Iba1 elevation, PA+metformin caused the Iba1 decline vs. metformin and PA treatment. GFAP level did not change in T2DM but rose in metformin and PA groups vs. control. PA+metformin administration diminished GFAP vs. PA. T2DM-induced changes were associated with dramatically decreased ZO-1 levels, while PA treatment increased it almost to control values. Conclusions. T2DM-induced UPR imbalance, activation of microglia, and impairments in cell integrity may trigger VMH dysfunction. Drug administration slightly improved ultrastructural changes in VMH, normalized UPR, and caused an astrocyte activation. PA and metformin exerted beneficial effects for counteracting diabetes-induced ER stress in VMH.
- 22 January 2022
- Published by Wiley in Neural Plasticity
- Vol. 2022, 1-26
Open AccessEffect of Propionic Acid on Diabetes-Induced Impairment of Unfolded Protein Response Signaling and Astrocyte/Microglia Crosstalk in Rat Ventromedial Nucleus of the Hypothalamus
Background. The aim was to investigate the influence of propionic acid (PA) on the endoplasmic reticulum (ER), unfolded protein response (UPR) state, and astrocyte/microglia markers in rat ventromedial hypothalamus (VMH) after type 2 diabetes mellitus (T2DM). Methods. Male Wistar rats were divided: (1) control, (2) T2DM, and groups that received the following (14 days, orally): (3) metformin (60mg/kg), (4) PA (60mg/kg), and (5) PA+metformin. Western blotting, RT-PCR, transmission electron microscopy, and immunohistochemical staining were performed. Results. We found T2DM-associated enlargement of ER cisterns, while drug administration slightly improved VMH ultrastructural signs of damage. GRP78 level was 2.1-fold lower in T2DM vs. control. Metformin restored GRP78 to control, while PA increased it by 2.56-fold and metformin+PAby 3.28-fold vs. T2DM. PERK was elevated by 3.61-fold in T2DM, after metforminby 4.98-fold, PA5.64-fold, and metformin+PA3.01-fold vs. control. A 2.45-fold increase in ATF6 was observed in T2DM. Metformin decreased ATF6 content vs. T2DM. Interestingly, PA exerted a more pronounced lowering effect on ATF6, while combined treatment restored ATF6 to control. IRE1 increased in T2DM (2.4-fold), metformin (1.99-fold), and PA (1.45-fold) groups vs. control, while metformin+PA fully normalized its content. The Iba1 level was upregulated in T2DM (5.44-fold) and metformin groups (6.88-fold). Despite PA treatment leading to a further 8.9-fold Iba1 elevation, PA+metformin caused the Iba1 decline vs. metformin and PA treatment. GFAP level did not change in T2DM but rose in metformin and PA groups vs. control. PA+metformin administration diminished GFAP vs. PA. T2DM-induced changes were associated with dramatically decreased ZO-1 levels, while PA treatment increased it almost to control values. Conclusions. T2DM-induced UPR imbalance, activation of microglia, and impairments in cell integrity may trigger VMH dysfunction. Drug administration slightly improved ultrastructural changes in VMH, normalized UPR, and caused an astrocyte activation. PA and metformin exerted beneficial effects for counteracting diabetes-induced ER stress in VMH.
- Open Access
- 19 October 2021
- Published by LLC Publishing house Medknyha in Endokrynologia
- Vol. 26 (3) , 271-280
Роль вітамін D-авто-/паракринної системи в розвитку метаболічного запального процесу в тканині печінки за експериментального цукрового діабету 2-го типу
На сьогодні дефіцит вітаміну D3 (холекальциферолу) та порушення сигналювання через рецептор вітаміну D (vitamin D receptor, VDR) вважають одними із факторів ризику розвитку гепатопатії на тлі цукрового діабету 2-го типу (ЦД2). Протизапальна і гепатопротекторна дія вітаміну D3 і в цілому наукове обґрунтування можливості його ефективного застосування в клініці ЦД2 активно висвітлюється в літературі, однак конкретні механізми залишаються недостатньо з’ясованими. Мета — дослідження впливу вітаміну D3 на рівень експресії мРНК ключових компонентів вітамін D-авто-/паракринної системи та цитокінового шляху фактора некрозу пухлини-альфа/транскрипційного фактора NF-κB (tumor necrosis factor alpha/nuclear factor kappa-light-chainenhancer of activated B cells, TNF-α/NF-κB) у тканині печінки за експериментального ЦД2. Матеріал і методи.У щурів-самців лінії Вістар викликали ЦД2 шляхом поєднання високожирової дієти та низької дози стрептозотоцину (25 мг/кг). Вимірювання вмісту триацилгліцеролів, холестеролу, вищих жирних кислот, загальних ліпідів та загального холестеролу в сироватці крові проводили стандартними біохімічними методами. Вміст 25(OH)D визначали методом імуноензимного аналізу. Аналіз експресії мРНК генів RelA, Iκb, Tnf-α, Cyp27a1, Cyp2r1,Cyp27b1 та Vdr проводили методом полімеразної ланцюгової реакції (ПЛР) у реальному часі. Результати. Експериментальний ЦД2 супроводжувався дефіцитом вітаміну D в організмі піддослідних тварин та розвитком діабетичної гепатопатії, свідченням чого є підвищення активності аланінамінотрансферази, а також акумулювання холестеролу, триацилгліцеролів і вищих жирних кислот у крові тварин. Показано зниження вмісту мРНК ключових компонентів вітамін D-авто-/паракринної системи в печінці діабетичних тварин, що призводило допорушення сигналювання через VDR та активування цитокінового шляху TNF-α/NF-κB. Введення вітаміну D3 в дозі 800 МО/кг протягом 30 діб тваринам із ЦД2 істотно нормалізувало експресію Vdr та ензимів метаболічного перетворення вітаміну D у тканині печінки та знижувало експресію прозапальних факторів — NF-κB та TNF-α. Висновки. Застосування вітаміну D3 в комплексній терапії ЦД2 потенційно може чинити гепатопротекторний ефект шляхом нормалізування функціонального стану вітамін D-авто-/паракринної системи печінки та модулювання прозапальних процесів, залежних від ядерного фактора κВ.
- 19 October 2021
- Published by LLC Publishing house Medknyha in Endokrynologia
- Vol. 26 (3) , 271-280
Open AccessРоль вітамін D-авто-/паракринної системи в розвитку метаболічного запального процесу в тканині печінки за експериментального цукрового діабету 2-го типу
На сьогодні дефіцит вітаміну D3 (холекальциферолу) та порушення сигналювання через рецептор вітаміну D (vitamin D receptor, VDR) вважають одними із факторів ризику розвитку гепатопатії на тлі цукрового діабету 2-го типу (ЦД2). Протизапальна і гепатопротекторна дія вітаміну D3 і в цілому наукове обґрунтування можливості його ефективного застосування в клініці ЦД2 активно висвітлюється в літературі, однак конкретні механізми залишаються недостатньо з’ясованими. Мета — дослідження впливу вітаміну D3 на рівень експресії мРНК ключових компонентів вітамін D-авто-/паракринної системи та цитокінового шляху фактора некрозу пухлини-альфа/транскрипційного фактора NF-κB (tumor necrosis factor alpha/nuclear factor kappa-light-chainenhancer of activated B cells, TNF-α/NF-κB) у тканині печінки за експериментального ЦД2. Матеріал і методи.У щурів-самців лінії Вістар викликали ЦД2 шляхом поєднання високожирової дієти та низької дози стрептозотоцину (25 мг/кг). Вимірювання вмісту триацилгліцеролів, холестеролу, вищих жирних кислот, загальних ліпідів та загального холестеролу в сироватці крові проводили стандартними біохімічними методами. Вміст 25(OH)D визначали методом імуноензимного аналізу. Аналіз експресії мРНК генів RelA, Iκb, Tnf-α, Cyp27a1, Cyp2r1,Cyp27b1 та Vdr проводили методом полімеразної ланцюгової реакції (ПЛР) у реальному часі. Результати. Експериментальний ЦД2 супроводжувався дефіцитом вітаміну D в організмі піддослідних тварин та розвитком діабетичної гепатопатії, свідченням чого є підвищення активності аланінамінотрансферази, а також акумулювання холестеролу, триацилгліцеролів і вищих жирних кислот у крові тварин. Показано зниження вмісту мРНК ключових компонентів вітамін D-авто-/паракринної системи в печінці діабетичних тварин, що призводило допорушення сигналювання через VDR та активування цитокінового шляху TNF-α/NF-κB. Введення вітаміну D3 в дозі 800 МО/кг протягом 30 діб тваринам із ЦД2 істотно нормалізувало експресію Vdr та ензимів метаболічного перетворення вітаміну D у тканині печінки та знижувало експресію прозапальних факторів — NF-κB та TNF-α. Висновки. Застосування вітаміну D3 в комплексній терапії ЦД2 потенційно може чинити гепатопротекторний ефект шляхом нормалізування функціонального стану вітамін D-авто-/паракринної системи печінки та модулювання прозапальних процесів, залежних від ядерного фактора κВ.
- Open Access
- 4 September 2020
- Published by Wiley in International Journal of Endocrinology
- Vol. 2020, 1-11
Vitamin D Auto-/Paracrine System Is Involved in Modulation of Glucocorticoid-Induced Changes in Angiogenesis/Bone Remodeling Coupling
Osteoporosis is a devastating side effect of chronic glucocorticoid (GC) treatment. Despite the crucial role of vitamin D (VD) in bone homeostasis, the precise molecular mechanisms of its action on GC-induced disturbances of bone remodeling remain undefined. The study was performed to elucidate the relation of VD status to GC-induced changes of the angiogenesis/osteogenesis/bone resorption coupling in bone tissue. Female Wistar rats received prednisolone (5 mg/kg of b.w.) with or without VD3 (1000 IU/kg of b.w., for 30 days). Biomechanical parameters of rat femurs were assessed by the three-point bending test. The levels of calcium, inorganic phosphate, activity of total alkaline phosphatase (ALP), and its isoenzymes were determined spectrophotometrically. Vascular endothelial growth factor-A (VEGF-A) and caspase-3 protein levels were detected by western blotting. Vdr and Cyp27b1 mRNAs were measured by qRT-PCR. Receptor activator of nuclear factor κB (RANK) expression in bone sections was visualized immunohistochemically. Serum 25(OH)D was assayed by ELISA. GC administration led to a decrease in maximal load (by 1.2-fold) and stiffness and toughness (by 1.3-fold), which was accompanied by a 3-fold reduction of 25(OH)D level, an elevation of the ALP bone isoenzyme activity in serum, hypocalcaemia, and hypophosphatemia. Along with prednisolone-induced VD deficiency, an impaired synthesis of Vdr (−30%) and Cyp27b1 (+71%) mRNA was observed, reflecting deregulation of bone tissue VD-auto-/paracrine system. GC caused an increase in caspase-3 content, suppressed the synthesis of the osteoclastic marker RANK, and altered angiogenesis/osteogenesis coupling by significantly reducing the level of VEGF-A.VD3 treatment restored serum 25(OH)D content and the expression of key components of the VD-auto-/paracrine system. VD3 supplementation diminished cell apoptosis and strongly improved angiogenesis/osteogenesis coupling as well as mineral metabolism and biomechanical parameters of femurs in GC-administered rats. Thus, VD3 can have a beneficial effect on the correction of GC-induced pathological changes in bone remodeling.
- 4 September 2020
- Published by Wiley in International Journal of Endocrinology
- Vol. 2020, 1-11
Open AccessVitamin D Auto-/Paracrine System Is Involved in Modulation of Glucocorticoid-Induced Changes in Angiogenesis/Bone Remodeling Coupling
Osteoporosis is a devastating side effect of chronic glucocorticoid (GC) treatment. Despite the crucial role of vitamin D (VD) in bone homeostasis, the precise molecular mechanisms of its action on GC-induced disturbances of bone remodeling remain undefined. The study was performed to elucidate the relation of VD status to GC-induced changes of the angiogenesis/osteogenesis/bone resorption coupling in bone tissue. Female Wistar rats received prednisolone (5 mg/kg of b.w.) with or without VD3 (1000 IU/kg of b.w., for 30 days). Biomechanical parameters of rat femurs were assessed by the three-point bending test. The levels of calcium, inorganic phosphate, activity of total alkaline phosphatase (ALP), and its isoenzymes were determined spectrophotometrically. Vascular endothelial growth factor-A (VEGF-A) and caspase-3 protein levels were detected by western blotting. Vdr and Cyp27b1 mRNAs were measured by qRT-PCR. Receptor activator of nuclear factor κB (RANK) expression in bone sections was visualized immunohistochemically. Serum 25(OH)D was assayed by ELISA. GC administration led to a decrease in maximal load (by 1.2-fold) and stiffness and toughness (by 1.3-fold), which was accompanied by a 3-fold reduction of 25(OH)D level, an elevation of the ALP bone isoenzyme activity in serum, hypocalcaemia, and hypophosphatemia. Along with prednisolone-induced VD deficiency, an impaired synthesis of Vdr (−30%) and Cyp27b1 (+71%) mRNA was observed, reflecting deregulation of bone tissue VD-auto-/paracrine system. GC caused an increase in caspase-3 content, suppressed the synthesis of the osteoclastic marker RANK, and altered angiogenesis/osteogenesis coupling by significantly reducing the level of VEGF-A.VD3 treatment restored serum 25(OH)D content and the expression of key components of the VD-auto-/paracrine system. VD3 supplementation diminished cell apoptosis and strongly improved angiogenesis/osteogenesis coupling as well as mineral metabolism and biomechanical parameters of femurs in GC-administered rats. Thus, VD3 can have a beneficial effect on the correction of GC-induced pathological changes in bone remodeling.
- Open Access
- 7 June 2018
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 9, 303
Vitamin D3 Modulates Impaired Crosstalk Between RANK and Glucocorticoid Receptor Signaling in Bone Marrow Cells After Chronic Prednisolone Administration
The effectiveness of vitamin D3 (cholecalciferol) in counteracting the side effects of glucocorticoid (GC) therapy has been demonstrated previously. Abnormalities in systemic hormonal and local (cytokine) regulation of bone marrow (BM) cells may underlie GC-induced imbalance between osteosynthesis and bone resorption. The cytokine system receptor activator of nuclear factor kappa-B (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) is considered as an integrating link in the NF-κB-mediated interaction of various cells involved in maintaining osteoblastic-osteoclastic balance, which makes it a pharmacological target for regulation and correction of the bone remodeling process. We studied GC-induced impairments of the RANKL/RANK/OPG axis in BM cells depending on vitamin D bioavailability and whether these changes were mediated by glucocorticoid (GR) and/or vitamin D (VDR) receptors. Female Wistar rats administered with prednisolone (5 mg/kg b.w., 30 days) showed a decrease in the GR protein level and the number of GR-positive BM cells. GC caused a marked elevation of RANKL and RANK levels in BM, while OPG decreased. Flow cytometry data indicated GC-elicited increase in the number of circulating RANK-positive osteoclast precursors (OCPs) in BM, peripheral blood, and spleen. In full accordance with the data that the interaction of RANKL-RANK leads to transcriptional activation of NF-κB and subsequent differentiation of osteoclasts, we found an increase in the level of phosphorylated p65 subunit of NF-κB with a simultaneous decrease in the NF-κB inhibitor (IκB) level. These changes were accompanied by vitamin D insufficiency and downregulated expression of CYP27B1 and VDR, which are responsible for synthesis and hormonal signaling of 1,25(OH)2D. Notably, we observed VDR and RANK co-localization in OCPs. Cholecalciferol co-administration (1,000 IU/kg b.w., 30 days) with prednisolone resulted in elevated GR synthesis in BM. Cholecalciferol prevented prednisolone-elicited disturbances of the RANKL/RANK/OPG, which correlated with improved bioavailability and vitamin D signaling through VDR. This caused the lowering of phosphoNF-κB p65 level and inhibiting NF-κB translocation to the nucleus that could reduce the circulating OCPs pool in BM, peripheral blood, and spleen. Our findings suggest that prednisolone-induced abnormalities in GR and RANKL/RANK/OPG signaling pathways are associated with the impairments of vitamin D auto/paracrine system in BM cells and can be ameliorated by cholecalciferol supplementation.
- 7 June 2018
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 9, 303
Open AccessVitamin D3 Modulates Impaired Crosstalk Between RANK and Glucocorticoid Receptor Signaling in Bone Marrow Cells After Chronic Prednisolone Administration
The effectiveness of vitamin D3 (cholecalciferol) in counteracting the side effects of glucocorticoid (GC) therapy has been demonstrated previously. Abnormalities in systemic hormonal and local (cytokine) regulation of bone marrow (BM) cells may underlie GC-induced imbalance between osteosynthesis and bone resorption. The cytokine system receptor activator of nuclear factor kappa-B (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) is considered as an integrating link in the NF-κB-mediated interaction of various cells involved in maintaining osteoblastic-osteoclastic balance, which makes it a pharmacological target for regulation and correction of the bone remodeling process. We studied GC-induced impairments of the RANKL/RANK/OPG axis in BM cells depending on vitamin D bioavailability and whether these changes were mediated by glucocorticoid (GR) and/or vitamin D (VDR) receptors. Female Wistar rats administered with prednisolone (5 mg/kg b.w., 30 days) showed a decrease in the GR protein level and the number of GR-positive BM cells. GC caused a marked elevation of RANKL and RANK levels in BM, while OPG decreased. Flow cytometry data indicated GC-elicited increase in the number of circulating RANK-positive osteoclast precursors (OCPs) in BM, peripheral blood, and spleen. In full accordance with the data that the interaction of RANKL-RANK leads to transcriptional activation of NF-κB and subsequent differentiation of osteoclasts, we found an increase in the level of phosphorylated p65 subunit of NF-κB with a simultaneous decrease in the NF-κB inhibitor (IκB) level. These changes were accompanied by vitamin D insufficiency and downregulated expression of CYP27B1 and VDR, which are responsible for synthesis and hormonal signaling of 1,25(OH)2D. Notably, we observed VDR and RANK co-localization in OCPs. Cholecalciferol co-administration (1,000 IU/kg b.w., 30 days) with prednisolone resulted in elevated GR synthesis in BM. Cholecalciferol prevented prednisolone-elicited disturbances of the RANKL/RANK/OPG, which correlated with improved bioavailability and vitamin D signaling through VDR. This caused the lowering of phosphoNF-κB p65 level and inhibiting NF-κB translocation to the nucleus that could reduce the circulating OCPs pool in BM, peripheral blood, and spleen. Our findings suggest that prednisolone-induced abnormalities in GR and RANKL/RANK/OPG signaling pathways are associated with the impairments of vitamin D auto/paracrine system in BM cells and can be ameliorated by cholecalciferol supplementation.
- 16 May 2018
- Published by Wiley in The Anatomical Record
- Vol. 301 (10) , 1734-1744
Nerve Regeneration in Conditions of HSV‐Infection and an Antiviral Drug Influence
Herpes simplex virus type I (HSV‐I) is a latent neuroinfection which can cause focal brain lesion. The role of HSV‐infection in nerve regeneration has not been studied so far. The aim of the work was to study sciatic nerve regeneration in the presence of HSV‐infection and the influence of an antiviral drug. BALB/c line mice were divided into five groups. Group 1 animals were infected with HSV‐I. After resolution of neuroinfection manifestations the sciatic nerve of these animals was crushed. Group 2 mice were administered acyclovir following the same procedures. Groups 3–5 mice served as controls. Thirty days after the operation distal nerve stumps and m.gastrocnemius were studied morphologically and biochemically. Ultrastructural organization of the sciatic nerve in control animals remained intact. Morphometric parameters of the nerves from the experimental groups have not reach control values. However, in the group 1 diameter of nerve fibers was significantly smaller than in the group 2. Both nerve regeneration and m.gastrocnemius reinnervation were confirmed. The muscle hypotrophy was found in groups 1, 2, and 3 (the muscle fibers diameter decreased). Metabolic changes in the muscles of the infected animals (groups 1 and 2) were more pronounced than in control groups 3 and 4. The levels of TBA‐active products, conjugated dienes, carbonyl and SH‐groups were reduced in m.gastrocnemius of the experimental groups, however no significant difference associated with acyclovir administration was found. HSV‐infection is not limited to the local neurodegenerative changes in the CNS but affects regeneration of the injured sciatic nerve. Anat Rec, 301:1734–1744, 2018.
- 16 May 2018
- Published by Wiley in The Anatomical Record
- Vol. 301 (10) , 1734-1744
Nerve Regeneration in Conditions of HSV‐Infection and an Antiviral Drug Influence
Herpes simplex virus type I (HSV‐I) is a latent neuroinfection which can cause focal brain lesion. The role of HSV‐infection in nerve regeneration has not been studied so far. The aim of the work was to study sciatic nerve regeneration in the presence of HSV‐infection and the influence of an antiviral drug. BALB/c line mice were divided into five groups. Group 1 animals were infected with HSV‐I. After resolution of neuroinfection manifestations the sciatic nerve of these animals was crushed. Group 2 mice were administered acyclovir following the same procedures. Groups 3–5 mice served as controls. Thirty days after the operation distal nerve stumps and m.gastrocnemius were studied morphologically and biochemically. Ultrastructural organization of the sciatic nerve in control animals remained intact. Morphometric parameters of the nerves from the experimental groups have not reach control values. However, in the group 1 diameter of nerve fibers was significantly smaller than in the group 2. Both nerve regeneration and m.gastrocnemius reinnervation were confirmed. The muscle hypotrophy was found in groups 1, 2, and 3 (the muscle fibers diameter decreased). Metabolic changes in the muscles of the infected animals (groups 1 and 2) were more pronounced than in control groups 3 and 4. The levels of TBA‐active products, conjugated dienes, carbonyl and SH‐groups were reduced in m.gastrocnemius of the experimental groups, however no significant difference associated with acyclovir administration was found. HSV‐infection is not limited to the local neurodegenerative changes in the CNS but affects regeneration of the injured sciatic nerve. Anat Rec, 301:1734–1744, 2018.